内镜时代巨大垂体腺瘤的治疗结局与手术要点:108例病例回顾
单中心回顾性分析2002年1月1日至2020年12月31日接受手术的108例巨大垂体腺瘤(最大直径≥4 cm)患者,平均术前肿瘤直径4.6±0.8 cm、平均体积25.9±19.2 cm³;97例仅经蝶入路,42例获全切,总体并发症发生率11.1%,最常见为脑脊液漏(5例,4.6%)与脑积水(4例,3.7%),1例死亡。
要点
- 巨大垂体腺瘤全切仅见于少数患者(42/108),总体并发症发生率为11.1%
- 最常见并发症为脑脊液漏(5例,4.6%)与脑积水(4例,3.7%)
- 作者认为应沿肿瘤长轴选择入路、尽量切除大部分肿瘤以降低残留肿瘤卒中风险
核心结论
- 巨大垂体腺瘤仍是手术难题,并发症显著;全切仅见于少数患者。
- 作者认为手术目标应包括尝试切除大部分肿瘤组织,通过沿肿瘤长轴调整入路以降低残留肿瘤卒中的风险。
- 作者认为需同时具备经蝶与多种经颅技术的经验,以减少并发症、改善结局。
研究设计与样本
- 单中心回顾性研究,作者复习在该机构接受垂体腺瘤切除的887例连续患者。
- 纳入2002年1月1日至2020年12月31日接受手术的108例巨大垂体腺瘤(最大直径≥4 cm)患者。
- 采用描述性统计分析患者人口学、临床表现、肿瘤影像特征、手术入路与术后结局。
主要发现
- 平均术前肿瘤直径为4.6±0.8 cm,平均体积为25.9±19.2 cm³。
- 97例仅经蝶入路,3例经颅切除,8例采用联合入路。
- 42例实现全切;77例肿瘤稳定、无需额外治疗,26例随后接受辅助放疗。
- 100例随访充分者中,14例因复发或肿瘤进展接受辅助治疗(再次手术和/或辅助放疗),6例复发者观察而未追加治疗。
- 总体并发症发生率为11.1%;最常见为脑脊液漏(5例,4.6%)与脑积水(4例,3.7%);1例死于术后残留肿瘤垂体卒中所致恶性脑水肿。
临床怎么用
- 作者认为巨大垂体腺瘤的手术目标应包括尝试切除大部分肿瘤组织,并沿肿瘤长轴调整入路以降低残留肿瘤卒中风险。
- 作者认为需具备经蝶与多种经颅技术的经验,以减少并发症、改善结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Giant (maximum diameter ≥ 4 cm) pituitary macroadenomas are complex tumors that require resection for decompression of optic nerves, relief of mass effect, and symptom improvement. Given the lack of surgical accessibility, the lateral extent of the lesions, and the invasion of the cavernous sinus, management presents a significant challenge. Transsphenoidal, transcranial, and combined approaches have been viable options for resection. The authors present their findings from a large series of patients to characterize giant pituitary adenomas, document outcomes, and outline surgical nuances in resection of these tumors. METHODS: The authors reviewed 887 consecutive patients who underwent resection of pituitary adenomas at a single institution. From this group, 108 patients with giant pituitary adenomas who underwent resection between January 1, 2002, and December 31, 2020, were identified for inclusion in the study. The patient demographics, clinical presentation, tumor imaging characteristics, surgical approaches, and postoperative outcomes were analyzed using descriptive statistics. RESULTS: The mean preoperative tumor diameter in this cohort was 4.6 ± 0.8 cm, with a mean volume of 25.9 ± 19.2 cm3. Ninety-seven patients underwent transsphenoidal approaches only, 3 underwent transcranial resection, and 8 patients underwent a combined approach. Gross-total resection was achieved in 42 patients. Tumor stability without a need for additional therapy was achieved in 77 patients, with 26 patients undergoing subsequent adjuvant radiotherapy. Among 100 patients with sufficient follow-up, 14 underwent adjuvant therapy-repeat operation and/or adjuvant radiation therapy-because of recurrence or tumor progression. Six patients with recurrence were observed without additional treatment. Overall, the morbidity associated with removal of these lesions was 11.1%; the most common morbidities were cerebrospinal fluid leak (5 patients, 4.6%) and hydrocephalus (4 patients, 3.7%). One death due to postoperative pituitary apoplexy of the residual tumor and malignant cerebral edema occurred in this cohort. CONCLUSIONS: Giant pituitary tumors still represent a surgical challenge, with significant morbidity. Gross-total resection occurs in a minority of patients. Surgical goals for removal of giant pituitary tumors should include attempts at removal of most tumor tissue to minimize the risk of residual tumor apoplexy by tailoring the approach along the major axis of the tumor. Experience with both transsphenoidal and multiple transcranial techniques is necessary for minimizing complications and improving outcomes.
引用
- Makarenko S, Alzahrani I, Karsy M, et al. Outcomes and surgical nuances in management of giant pituitary adenomas: a review of 108 cases in the endoscopic era. J Neurosurg. 2022. PMID: 35061979. doi:10.3171/2021.10.JNS21659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。